News | Radiation Therapy | June 24, 2021

The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families

The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients’ bones. Once a standard practice, the American Society for Radiation Oncology (ASTRO) has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.

Multiple cancer metastasis to the pelvic bone and femur bones. Getty Images


June 24, 2021 — An effort by the Michigan Radiation Oncology Quality Consortium reduced excessive radiation treatments for bone metastases by 80% at health care centers across the state, according to findings published in Practical Radiation Oncology.

The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients’ bones. Once a standard practice, the American Society for Radiation Oncology (ASTRO) has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.

“The goal was to save medical resources as well as reduce the burden on patients,” said study first author Elizabeth Jaworski, M.D., a house officer in the Department of Radiation Oncology at U-M. “Patients and their loved ones may have to miss work to get these treatments. There may be travel costs, parking costs — it all adds up. And studies have found that getting more treatments isn’t likely to lower their cancer pain any better.”

The Michigan Radiation Oncology Quality Consortium, a collaborative quality initiative funded by Blue Cross Blue Shield of Michigan and the Blue Care Network, made a push across its member sites to reduce the procedures in 2018. By the fall of 2020, the use of extended-fraction for bone metastases fell from nearly 15% to just over 3% at 28 radiation facilities across the state.

More extended treatment was likely to happen at non-teaching hospitals and among physicians who had been practicing longer, the study of more than 1,400 patients found.

“We were very pleased to see this effort have such an impact in Michigan. In some parts of the country, use is still higher than 15%,” said senior study author James Hayman, M.D., M.B.A., a radiation oncologist at U-M and co-director of the quality consortium. “And, while more than 10 treatments may be appropriate in rare cases, we’re continuing to look at ways to reduce the overall number of treatments even further.”

Paper cited: “Contemporary practice patterns for palliative radiotherapy of bone metastases: Impact of a quality improvement project on extended fractionation,” Practical Radiation Oncology. DOI: 10.1016/j.prro.2021.05.002


Related Content

News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Stereotactic Body Radiation Therapy (SBRT) | American Society for Radiation Oncology

Sept. 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival ...

Time October 15, 2025
arrow
Subscribe Now